Of particular significance, patients with high PBF/Src expression had a significantly higher proportion of HER2-positive and TNBC tumours than those with low PBF/Src expression (Fig. 5F), which was reflected in greater reduction in overall survival (Fig. 5G) compared to other patient groups (Supplementary Fig. 8B). Here, SRC is linked to neoplasm.